The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Makarik A.A.

N.I. Pirogov Russian National Research Medical University

Lystsev D.V.

I.M. Sechenov First Moscow State Medical University

Logutova L.S.

V.I. Krasnopolsky Moscow Regional Research Institute of Obstetrics and Gynecology

Features of the course of pregnancy in patients with aplastic anemia

Authors:

Makarik A.A., Lystsev D.V., Logutova L.S.

More about the authors

Read: 164 times


To cite this article:

Makarik AA, Lystsev DV, Logutova LS. Features of the course of pregnancy in patients with aplastic anemia. Russian Bulletin of Obstetrician-Gynecologist. 2025;25(5):15‑21. (In Russ.)
https://doi.org/10.17116/rosakush20252505115

Recommended articles:
Sexual function of women during pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):112-117
Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):517-524
Immu­nological aspe­cts of reccurent pregnancy loss. Russian Journal of Human Reproduction. 2024;(5):64-71
Autoimmune hepa­titis: pitfalls of diagnosis and therapy (clinical case). Russian Journal of Evidence-Based Gastroenterology. 2024;(4):95-103
Functional cyto­kine redu­ndancy in pregnancy. Russian Journal of Human Reproduction. 2024;(6):73-80

References:

  1. World Health Organisation. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. 2011.
  2. Miano M, Dufour C. The diagnosis and treatment of aplastic anemia: a review. Int J Hematol. 2015;101:6:527-535. 
  3. Benson CS, Shah A, Frise MC, Frise CJ. Iron deficiency anaemia in pregnancy: A contemporary review. Obstet Med. 2021;14:2:67-76. 
  4. Atadzhanyan AS. Anemia in pregnancy: clinico-pathogenetic approaches to the management of pregnancy. Zhurnal akusherstva i zhenskikh boleznei. 2017;66:5:56-63. (In Russ.).
  5. James AH. Iron deficiency anemia in pregnancy. Obstet Gynecol. 2021;138:4:663-674. 
  6. Kaufman DW, Kelly JP, Levy M, Shapiro S. The Drug etiology of agranulocytosis and aplastic anemia. Oxford; New York: 1991.
  7. Issaragrisil S, Kaufman D, Anderson T, Chansung K, Leaverton P, Shapiro S, Young NS, The Aplastic Anemia Study G. The epidemiology of aplastic anemia in Thailand. Blood. 2006;107:1299-1307.
  8. Hamerschlak N, Maluf E, Pasquini R, Eluf-Neto J, Moreira FR, Cavalcanti AB, Okano ÍR, Falcão RP, Pita MT, Loggetto SR, Rosenfeld LG, Lorand-Metze IGH. Incidence of aplastic anemia and agranulocytosis in Latin America: the LATIN study. Sao Paulo Med J. 2005;123:101-104. 
  9. Horowitz KM, Ingardia CJ, Borgida AF. Anemia in pregnancy. Clin Lab Med. 2013;33:2:281-291. 
  10. Jessani S, Saleem S, Hoffman MK, Goudar SS, Derman RJ, Moore JL, Garces A, Figueroa L, Krebs NF, Okitawutshu J, Tshefu A, Bose CL, Mwenechanya M, Chomba E, Carlo WA, Das PK, Patel A, Hibberd PL, Esamai F, Liechty EA, Bucher S, Nolen TL, Koso-Thomas M, Miodovnik M, McClure EM, Goldenberg RL. Association of haemoglobin levels in the first trimester and at 26—30 weeks with fetal and neonatal outcomes: a secondary analysis of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial. BJOG. 2021;128:9:1487-1496.
  11. Rahman MM, Abe SK, Rahman MS, Kanda M, Narita S, Bilano V, Ota E, Gilmour S, Shibuya K. Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis. Am J Clin Nutr. 2016;103:2:495-504. 
  12. Ali SA, Tikmani SS, Saleem S, Patel AB, Hibberd PL, Goudar SS, Dhaded S, Derman RJ, Moore JL, McClure EM, Goldenberg RL. Hemoglobin concentrations and adverse birth outcomes in South Asian pregnant women: findings from a prospective Maternal and Neonatal Health Registry. Reprod Health. 2020;17:Suppl 2:154. 
  13. Daru J, Zamora J, Fernández-Félix BM, Vogel J, Oladapo OT, Morisaki N, Tunçalp Ö, Torloni MR, Mittal S, Jayaratne K, Lumbiganon P, Togoobaatar G, Thangaratinam S, Khan KS. Risk of maternal mortality in women with severe anaemia during pregnancy and post partum: a multilevel analysis. Lancet Glob Health. 2018;6:5:e548-e554.
  14. Riveros-Perez E. Aplastic anemia during pregnancy: a review of obstetric and anesthetic considerations. International Journal of Women’s Health. 2018;28:10:117-125. 
  15. Bär C, Povedano JM, Serrano R, Benitez-Buelga C, Popkes M, Formentini I, M Bobadilla, Bosch F, Blasco MA. Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia. Blood. 2016;127:1770-1779.
  16. Akram Z, Ahmed P, Kajigaya S, Satti TM, Satti HS, Chaudhary QUN, Gutierrez-Rodrigues F, Ibanez PF, Feng X, Mahmood SK, Ghafoor T, Shahbaz N, Khan MA, Sultan A. Epidemiological, clinical and genetic characterization of aplastic anemia patients in Pakistan. Ann Hematol. 2019;98:301-312. 
  17. Shamrai VS, Kozyreva VA. Pregnancy due to diseases of the blood system: risks, management tactics, prospects. Glavnyi vrach Yuga Rossii. 2017;1:53:13-18. (In Russ.).
  18. Mikhailova EA, Fidarova ZT, Ustinova EN. Combined immunosuppressive therapy for patients with aplastic anemia: the effectiveness of repeated courses of antithymocyte globulin. Gematologiya i transfusiologiya. 2014;59:4:11-18. (In Russ.).
  19. Aisarieva BK, Raimzhanov AR, Aitbaev K. Aplastic anemia: modern ideas about pathogenesis and therapy. Molodoi uchenyi. 2011;9:228-235. (In Russ.).
  20. Peslak SA, Olson T, Babushok DV. Diagnosis and treatment of aplastic anemia. Curr Treat Options Oncol. 2017;18:12:70. 
  21. Young NS, Kaufman DW. The epidemiology of acquired aplastic anemia. Haematologica. 2008;93:4:489-492. 
  22. Pierri F, Dufour C. Management of aplastic anemia after failure of frontline immunosuppression. Expert Rev Hematol. 2019;12:10:809-819. 
  23. Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS. A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood. 1996;88:6:1983-1991.
  24. Ismail M, Gibson FM, Gordon-Smith EC, Rutherford TR. Bcl-2 and Bcl-x expression in the CD34+ cells of aplastic anaemia patients: relationship with increased apoptosis and upregulation of Fas antigen. Br J Haematol. 2001;113:3:706-712. 
  25. Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol. 1995;91:1:245-252. 
  26. Holmberg LA, Seidel K, Leisenring W, Torok-Storb B. Aplastic anemia: analysis of stromal cell function in long-term marrow cultures. Blood. 1994;84:11:3685-3690.
  27. Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, Mizoguchi T, Wei Q, Lucas D, Ito K, Mar JC, Bergman A, Frenette PS. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature. 2013;502:7473:637-643.  https://doi.org/10.1038/nature12612
  28. Wu L, Mo W, Zhang Y, Deng H, Li Y, Zhou R, Zhang L, Pan S, Wang S. Impairment of hematopoietic stem cell niches in patients with aplastic anemia. Int J Hematol. 2015;102:6:645-653. 
  29. Chen J, Desierto MJ, Feng X, Biancotto A, Young NS. Immune-mediated bone marrow failure in C57BL/6 mice. Exp Hematol. 2015;43:256-267. 
  30. Chuncharunee S, Wong R, Rojnuckarin P, Chang C-S, Chang KM, Lu M-Y, Hwang W-L, Koh LP, Chen T-Y, Leung AY, Norasetthada L, Wang S-C, Chang M-C, Wu K-H, Issaragrisil S. Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study. Int J Hematol. 2016;104:454-461. 
  31. Wang L, Liu H. Pathogenesis of aplastic anemia. Hematology. 2019;24:1:559-566. 
  32. Zaimoku Y, Takamatsu H, Hosomichi K, Ozawa T, Nakagawa N, Imi T, Maruyama H, Katagiri T, Kishi H, Tajima A, Muraguchi A, Kashiwase K, Nakao S. Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia. Blood. 2017;129:2908-2916.
  33. Marsh JC, Kulasekararaj AG. Management of the refractory aplastic anemia patient: what are the options? Blood. 2013;122:3561-3567.
  34. Brummendorf TH, Maciejewski JP, Mak J, Young NS, Lansdorp PM. Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood. 2001;97:895-900. 
  35. Tichelli A, Schrezenmeier H, Socie G, Marsh J, Bacigalupo, A Dührsen U, Franzke A, Hallek M, Thiel E, Wilhelm M, Höchsmann B, Barrois, A Champion K, Passweg JR. A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA working party of the European group for blood and marrow transplantation. Blood. 2011;117:4434-4441.
  36. Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017; 129:1428-1436.
  37. Ma J, Luo F, Yan L. Neonatal outcomes and related risk factors of 30 cases with aplastic anemia in pregnancy: A retrospective study. Early Hum Dev. 2023;185:105855. https://doi.org/10.1016/j.earlhumdev.2023.105855
  38. A comprehensive program for the diagnosis of aplastic anemia with the determination of prognostically significant pathogenetic features of the disease. Guidelines. St. Petersburg: ViT-print Agency. 2015;32. (In Russ.).
  39. Young NS. Current concepts in the pathophysiology and treatment of aplastic anemia. ASH Education Book. 2013;2013:1:76-81. 
  40. Riveros-Perez E. Aplastic anemia during pregnancy: a review of obstetric and anesthetic considerations. Int J Women’s Health. 2018;28:10:117-125. 
  41. Bo L, Mei-Ying L, Yang Z, Shan-Mi W, Xiao-Hong Z (2015): Aplastic anemia associated with pregnancy: maternal and fetal complications. J Matern Fetal Neonatal Med. 2016;29:7:1120-1124.
  42. Ivanov DO, Yur’ev VK, Shevtsova KG, Moiseeva KE. Incidence of anemia in pregnant women and its impact on infant mortality. Pediatriya. 2019;10:1:43-48. (In Russ.).
  43. Kucher MA, Pevtsov DE, Estrina MA, Ivanova NE, Makarenko OA. Features of blood transfusion therapy during hematopoietic stem cell transplantation. Scientific notes of St. Petersburg State Medical University named after. I.P. Pavlova. 2016;4:61-64. (In Russ.).
  44. Shilova ER, Gritsaev SV, Karmatskaya II. Mycophenolic acid preparations in the treatment of patients with aplastic anemia. Vestnik gematologii. 2014;1:40-47. (In Russ.).
  45. Upryamova EYu, Golovina AA, Shifman EM. Anesthetic tactics during delivery of patients with complement-associated pathology. Clinical observation of a pregnant woman with paroxysmal nocturnal hemobinuria. Anestesiologiya i reanimatologiya. 2017;62:1:56-60. (In Russ.).
  46. Glazanova TV, Gritsaev SV, Shilova ER, Pavlova IE, Chubukina ZhV, Rozanova OE, Abdulkadyrova KM, Chechetkin AV. Development of allogeneic antibodies to leukocyte and platelet antigens (anti-HLA and anti-HRA) in patients with blood diseases due to transfusions of blood components. Gematologiya i transfusiologiya. 2015;60:4:26-29. (In Russ.).
  47. Kwon JY, Lee Y, Shin JC, Lee JW, Rha JG, Kim SP. Supportive management of pregnancy-associated aplastic anemia. Int J Gynaecol Obstet. 2006;95:2:115-120. 
  48. Rakhmani AF, Mikhailova EA, Dubinkin IV. Tactics of transfusion therapy with platelet concentrates in patients with hematopoiesis depressions. Gematologiya i transfusiologiya. 2017;62:4:218-222. (In Russ.).
  49. Goncharova MA, Petrov YuA, Kislyakova NN, Avrutskaya VV. Rare forms of anemia: aplastic anemia and pregnancy. Healthy mother — healthy offspring: collection of materials from the intra-university scientific and practical conference. Rostov-on-Don: Rostov State Medical University. 2020;106-115. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.